376 related articles for article (PubMed ID: 36987181)
21. Stimuli-Sensitive Biodegradable and Amphiphilic Block Copolymer-Gemcitabine Conjugates Self-Assemble into a Nanoscale Vehicle for Cancer Therapy.
Duan Z; Zhang Y; Zhu H; Sun L; Cai H; Li B; Gong Q; Gu Z; Luo K
ACS Appl Mater Interfaces; 2017 Feb; 9(4):3474-3486. PubMed ID: 28029039
[TBL] [Abstract][Full Text] [Related]
22. Polyrotaxanes for applications in life science and biotechnology.
Li JJ; Zhao F; Li J
Appl Microbiol Biotechnol; 2011 Apr; 90(2):427-43. PubMed ID: 21360153
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
24. Bioresponsive and multifunctional cyclodextrin-based non-viral nanocomplexes in cancer therapy: Building foundations for gene and drug delivery, immunotherapy and bioimaging.
Lu Q
Environ Res; 2023 Oct; 234():116507. PubMed ID: 37364628
[TBL] [Abstract][Full Text] [Related]
25. Supramolecular Nanostructures Based on Cyclodextrin and Poly(ethylene oxide): Syntheses, Structural Characterizations and Applications for Drug Delivery.
Zheng Y; Wyman IW
Polymers (Basel); 2016 May; 8(5):. PubMed ID: 30979290
[TBL] [Abstract][Full Text] [Related]
26. Amphiphilic cyclodextrin nanoparticles.
Varan G; Varan C; Erdoğar N; Hıncal AA; Bilensoy E
Int J Pharm; 2017 Oct; 531(2):457-469. PubMed ID: 28596142
[TBL] [Abstract][Full Text] [Related]
27. Codelivery of doxorubicin and camptothecin by dual-responsive unimolecular micelle-based β-cyclodextrin for enhanced chemotherapy.
Gao YE; Bai S; Ma X; Zhang X; Hou M; Shi X; Huang X; Chen J; Wen F; Xue P; Kang Y; Xu Z
Colloids Surf B Biointerfaces; 2019 Nov; 183():110428. PubMed ID: 31415956
[TBL] [Abstract][Full Text] [Related]
28. Self-assembled cyclodextrin aggregates and nanoparticles.
Messner M; Kurkov SV; Jansook P; Loftsson T
Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.
Bibby DC; Davies NM; Tucker IG
Int J Pharm; 2000 Mar; 197(1-2):1-11. PubMed ID: 10704788
[TBL] [Abstract][Full Text] [Related]
30. Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs.
Duchene D; Cavalli R; Gref R
Curr Pharm Biotechnol; 2016; 17(3):248-55. PubMed ID: 26517333
[TBL] [Abstract][Full Text] [Related]
31. Amphiphilic Cyclodextrin Derivatives for Targeted Drug Delivery to Tumors.
Erdogar N; Varan G; Bilensoy E
Curr Top Med Chem; 2017; 17(13):1521-1528. PubMed ID: 28017158
[TBL] [Abstract][Full Text] [Related]
32. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
[TBL] [Abstract][Full Text] [Related]
33. Supramolecular cyclodextrin-based drug nanocarriers.
Simões SM; Rey-Rico A; Concheiro A; Alvarez-Lorenzo C
Chem Commun (Camb); 2015 Apr; 51(29):6275-89. PubMed ID: 25679097
[TBL] [Abstract][Full Text] [Related]
34. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications.
Moya-Ortega MD; Alvarez-Lorenzo C; Concheiro A; Loftsson T
Int J Pharm; 2012 May; 428(1-2):152-63. PubMed ID: 22388054
[TBL] [Abstract][Full Text] [Related]
35. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery.
Varan G; Benito JM; Mellet CO; Bilensoy E
Beilstein J Nanotechnol; 2017; 8():1457-1468. PubMed ID: 28900599
[No Abstract] [Full Text] [Related]
36. Biodegradable Polyester of Poly (Ethylene glycol)-sebacic Acid as a Backbone for β -Cyclodextrin-polyrotaxane: A Promising Gene Silencing Vector.
Ghodke S; Mahajan P; Gupta K; Ver Avadhani C; Dandekar P; Jain R
Curr Gene Ther; 2019; 19(4):274-287. PubMed ID: 31393245
[TBL] [Abstract][Full Text] [Related]
37. Chemically cross-linked and grafted cyclodextrin hydrogels: from nanostructures to drug-eluting medical devices.
Concheiro A; Alvarez-Lorenzo C
Adv Drug Deliv Rev; 2013 Aug; 65(9):1188-203. PubMed ID: 23631979
[TBL] [Abstract][Full Text] [Related]
38. Polymeric Nanocarriers Based on Cyclodextrins for Drug Delivery: Host-Guest Interaction as Stimuli Responsive Linker.
Peng L; Liu S; Feng A; Yuan J
Mol Pharm; 2017 Aug; 14(8):2475-2486. PubMed ID: 28463008
[TBL] [Abstract][Full Text] [Related]
39. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
Parrot-Lopez H; Perret F; Bertino-Ghera B
Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
[TBL] [Abstract][Full Text] [Related]
40. Cyclodextrin-Based Nanosystems as Drug Carriers for Cancer Therapy.
Sivakumar PM; Peimanfard S; Zarrabi A; Khosravi A; Islami M
Anticancer Agents Med Chem; 2020; 20(11):1327-1339. PubMed ID: 31490765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
